APPARENT ABSENCE OF BCL-2 REARRANGEMENT IN 10 SAUDI FOLLICULAR LYMPHOMAS - A PRELIMINARY-REPORT

被引:2
|
作者
NASRIN, N [1 ]
AKHTAR, M [1 ]
ASHRAF, M [1 ]
HANNAN, MA [1 ]
机构
[1] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PATHOL & LAB MED,RIYADH 11211,SAUDI ARABIA
关键词
D O I
10.5144/0256-4947.1994.219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Specific chromosomal translocations are often found to be associated with distinct types of human neoplasms. The t(14;18) is considered to be a cytogenetic hallmark of the follicular lymphomas found mostly in American patients. This chromosomal translocation occurs through a 3' untranslated region (either major breakpoint region [mbr] or minor cluster region [mcr]) of the bcl-2 proto-oncogene in chromosome 18 and the J(H) region of the immunoglobulin (Ig) gene in chromosome 14. In the present study, the polymerase chain reaction (PCR) was used to detect a fusion DNA fragment generated from bcl-2/J(H) rearrangement either through mbr or mcr in 10 follicular lymphomas in Saudi Arab patients. Surprisingly, none of these cases showed any evidence of bcl-2 gene rearrangement through mbr or mcr. The absence of usual bcl-2/J(H) recombination in Saudi follicular lymphomas is intriguing and may suggest that the occurrence and mode of bcl-2 gene rearrangement in this lymphoma varies in different patient populations.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 50 条
  • [31] The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphomas (PCFL)
    Lawnicki, LC
    Aoun, P
    Chan, WC
    Weisenburger, DD
    Greiner, TC
    LABORATORY INVESTIGATION, 2001, 81 (01) : 170A - 170A
  • [32] The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphomas (PCFL)
    Lawnicki, LC
    Aoun, P
    Chan, WC
    Weisenburger, DD
    Greiner, TC
    MODERN PATHOLOGY, 2001, 14 (01) : 170A - 170A
  • [33] THE BCL-2/JH GENE REARRANGEMENT IS UNDETECTABLE IN HODGKINS LYMPHOMAS - RESULTS FROM THE GERMAN HODGKIN TRIAL
    NOLTE, M
    WERNER, M
    SPANN, W
    SCHNABEL, B
    VONWASIELEWSKI, R
    WILKENS, L
    HUBNER, K
    FISCHER, R
    GEORGII, A
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 426 (01): : 37 - 41
  • [34] Bcl-2 GENE REARRANGEMENT DETERMINED BY PCR AS AMEAN TO DETECT MINIMAL RESIDUAL DISEASE INMALIGNANT LYMPHOMAS
    向直富
    卢玉英
    赖永榕
    陈燕
    李慧玉
    邹萍
    ChineseJournalofCancerResearch, 1999, (01) : 3 - 5
  • [35] BCL-2 GENE REARRANGEMENT ANALYSIS OF JAPANESE FOLLICULAR LYMPHOMAS BY POLYMERASE CHAIN-REACTION IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE SPECIMENS
    MITANI, S
    AOKI, N
    MIZUTANI, S
    FUJIWARA, M
    KITAGAWA, T
    UEHARA, T
    MORI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (01): : 37 - 41
  • [36] Reliable detection of clonal IgH/Bcl-2 MBR rearrangement in follicular lymphoma: Methodology and clinical significance
    Goff, LK
    Iqbal, S
    Jenner, MJ
    Summers, KE
    Matthews, J
    Norton, AJ
    Calaminici, M
    Rohatiner, AZS
    Fitzgibbon, J
    Davies, AJ
    Lister, TA
    BLOOD, 2003, 102 (11) : 633A - 633A
  • [37] REARRANGEMENT OF THE BCL-2 GENE IN FOLLICULAR LYMPHOMA - DETECTION BY PCR IN BOTH FRESH AND FIXED TISSUE SAMPLES
    LIU, J
    JOHNSON, RM
    TRAWEEK, ST
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1993, 2 (04) : 241 - 247
  • [38] Frequency of the Bcl-2/IgH rearrangement in normal individuals:: Implications for the monitoring of disease in patients with follicular lymphoma
    Summers, KE
    Goff, LJ
    Wilson, AG
    Gupta, RK
    Lister, TA
    Fitzgibbon, J
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 420 - 424
  • [39] BCL-2 ONCOGENE REARRANGEMENT IN FOLLICULAR AND DIFFUSE LARGE-CELL AND MIXED-CELL LYMPHOMA
    YUNIS, JJ
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 37 - 40
  • [40] Molecular characteristics and prognostic significance of bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients
    Radojkovic, M.
    Ristic, S.
    Colovic, M.
    Cemerikic-Martinovic, V.
    Radojkovic, D.
    Krtolica, K.
    NEOPLASMA, 2008, 55 (05) : 421 - 427